Abstract
Immunotherapy greatly improves clinical outcomes in treated patients with cancer. However, the long-lasting immune response and long duration of therapy could induce long-term adverse effects owing to the chronic inflammation induced. Type 2 diabetes is now recognized as an inflammatory disease. In addition, immunotherapy is concerned with increase in the production of tumor necrosis factor-α, interleukin-2, and interferon-γ, which are involved in the inflammatory process. Based on these observations, we hypothesized that anti-programmed cell death-1 (anti-PD-1) and/or anticytotoxic T-lymphocyte-associated protein-4 therapy could contribute to type 2 diabetes genesis in treated patients. Therefore, to evaluate this hypothesis, we studied HbA1c levels during follow-up in patients treated with anti-PD-1 and/or anticytotoxic T-lymphocyte-associated protein-4 therapy. A prospective and observational study was performed in an oncodermatology department (Saint-Louis Hospital, Paris, France) from March 2015 to February 2017. Sixty-two patients meeting the inclusion criteria were enrolled. Forty-three patients had paired HbA1c measurements during their follow-up period and were analyzed. The median follow-up was 3 months. We noted an i...Continue Reading
References
Jul 6, 2000·Circulation·A FestaS M Haffner
Jan 30, 2002·Diabetes Care·Curt L RohlfingDavid E Goldstein
Sep 24, 2004·Annals of Internal Medicine·Kay-Tee KhawNicholas Day
Jul 28, 2009·Nature Medicine·Shawn WinerH-Michael Dosch
Jul 28, 2009·Nature Medicine·Satoshi NishimuraRyozo Nagai
Dec 29, 2009·Nature Immunology·Wataru IseKenneth M Murphy
May 21, 2010·Diabetes·Kunihiro MatsushitaElizabeth Selvin
Sep 8, 2010·The Journal of Experimental Medicine·Kaori SakuishiAna C Anderson
Nov 15, 2011·Cardiovascular Diabetology·Yao LiuJian-dong Li
Feb 13, 2013·Metabolism: Clinical and Experimental·Bimin ShiXueguang Zhang
Nov 2, 2013·Diabetes Research and Clinical Practice·Haleh AshrafGholamreza Davoodi
Jul 19, 2014·Immunity·Joanne C McNelis, Jerrold M Olefsky
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
Apr 22, 2015·The New England Journal of Medicine·Michael A PostowF Stephen Hodi
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Mar 8, 2016·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Constantin A DasanuRyszard Skulski
Apr 4, 2017·British Journal of Pharmacology·A C Foks, J Kuiper
Sep 10, 2017·Journal of Diabetes and Its Complications·Christine Emma Maria KrabbeHenry Völzke
May 29, 2018·Cancer Immunology, Immunotherapy : CII·Marie-Léa GauciJean-François Gautier
Oct 10, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marie-Léa GauciAurélien Marabelle
Citations
Aug 20, 2019·Acta Diabetologica·Lucien MarchandChristine Cugnet-Anceau
Jan 3, 2020·The Journal of Clinical Investigation·Michael Dougan, Massimo Pietropaolo
Nov 12, 2019·Internal Medicine·Nobumasa OharaShin-Ichi Kosugi
Dec 22, 2020·Diabetes Research and Clinical Practice·Amanda LeiterEmily J Gallagher